KMT Hepatech earns CCAC accreditation

KMT Hepatech earns CCAC accreditation KMT Hepatech has recently applied for and received a Certificate of GAP-Good Animal Practice® from the Canadian Council on Animal Care (CCAC). The CCAC…

0 Comments
Read more about the article KMT Hepatech earns CCAC accreditation
KMT Hepatech earns CCAC accreditation

KMT Hepatech – 20 years

KMT Hepatech - 20 years February marks 20 years since KMT Hepatech (now part of the PhoenixBio Group) was incorporated. It has been a long journey and a great…

0 Comments
Read more about the article KMT Hepatech – 20 years
Dr. N. Kneteman and Dr. L. Tyrrell receiving ASTech Foundation Award

PXB-cells®: Robust Human Hepatocytes

An open access paper providing a detailed characterization of PXB-cells® was published in late 2020 in PLoS ONE journal. These cells are proven to be a reliable in vitro…

0 Comments
Read more about the article PXB-cells®: Robust Human Hepatocytes
Figure 1. PXB-cells 12 days after plating. Yellow arrowheads indicate examples of bile canaliculi

Toxicity of Aflatoxin B1 in vitro and in vivo

The assessment of safety and the toxicity profile of chemical and biological entities remains a challenge. Despite ongoing efforts to better understand the mechanisms underlying safety and toxicity, ~30%…

0 Comments
Read more about the article Toxicity of Aflatoxin B1 in vitro and in vivo
Toxicity of Aflatoxin B1 in vitro (PXB-cells) and in vivo (PXB-mouse)

Oligonucleotides and the humanized liver mouse model

Oligonucleotides remain compounds of high interest in drug development, especially with recent advancements in chemistry and delivery technologies. With more compounds progressing further in preclinical development, the need for…

0 Comments
Read more about the article Oligonucleotides and the humanized liver mouse model
1001_Publications with PXB-mouse and PXB-cells in oligonucleotides studies